NLRP3 and heart failure: Elevated levels of β-hydroxybutyrate (β-HB) bind to the NLRP3 inflammasome, inhibiting its activity and thereby reducing the release of the inflammatory factors IL-1β and IL-18, slowing myocardial fibrosis and promoting the recovery of the ejection fraction during heart failure progression (Deng et al., 2021).